<?xml version="1.0" encoding="UTF-8"?>
<p>Gastrointestinal symptoms mainly in the form of diarrhea were common (~33%‐73%) in patients with SARS‐CoV infection.
 <xref rid="jmv26066-bib-0104" ref-type="ref">
  <sup>104</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0107" ref-type="ref">
  <sup>107</sup>
 </xref> Although this manifestation may have been uncommon at the first day of presentation, these symptoms became apparent at a variable time later.
 <xref rid="jmv26066-bib-0107" ref-type="ref">
  <sup>107</sup>
 </xref> In “atypical” presentations, a patient may have had no apparent respiratory symptoms while yet suffering from fever and/or diarrhea.
 <xref rid="jmv26066-bib-0108" ref-type="ref">
  <sup>108</sup>
 </xref> When using RNA detection methods, stool samples were commonly positive at a later peak timing than respiratory samples, but not as late as urine reactive samples.
 <xref rid="jmv26066-bib-0107" ref-type="ref">
  <sup>107</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0109" ref-type="ref">
  <sup>109</sup>
 </xref> Any such sampling that depends on amplification technology must bear in mind the diagnostic pitfalls inherent, and repeat sampling increases the positive and hence diagnostic yields.
 <xref rid="jmv26066-bib-0110" ref-type="ref">
  <sup>110</sup>
 </xref> SARS patients diagnosed by one or several laboratory methods had a positive stool screen for the viral genome in approximately 28% to 78% of patients.
 <xref rid="jmv26066-bib-0105" ref-type="ref">
  <sup>105</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0111" ref-type="ref">
  <sup>111</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0112" ref-type="ref">
  <sup>112</sup>
 </xref> The majority of these were found in the period of 9 to 14 days after the onset of clinical infection.
 <xref rid="jmv26066-bib-0105" ref-type="ref">
  <sup>105</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0107" ref-type="ref">
  <sup>107</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0111" ref-type="ref">
  <sup>111</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0113" ref-type="ref">
  <sup>113</sup>
 </xref> By the third week after onset of infection, viral RNA could be amplified in almost 2/3 of patients.
 <xref rid="jmv26066-bib-0107" ref-type="ref">
  <sup>107</sup>
 </xref> Detection in stool samples continued for up to 10 weeks.
 <xref rid="jmv26066-bib-0106" ref-type="ref">
  <sup>106</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0112" ref-type="ref">
  <sup>112</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0114" ref-type="ref">
  <sup>114</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0115" ref-type="ref">
  <sup>115</sup>
 </xref> Prolonged excretion detected with genetic amplification correlated with increasing patient comorbidities.
 <xref rid="jmv26066-bib-0114" ref-type="ref">
  <sup>114</sup>
 </xref> Increased viral load quantitated in stool samples correlated with greater likely for the patient to suffer with diarrhea.
 <xref rid="jmv26066-bib-0105" ref-type="ref">
  <sup>105</sup>
 </xref> Most of the latter studies were not simultaneously assessing viral culture for pathogen viability.
</p>
